Treace Medical Concepts, Inc. (TMCI)

NASDAQ: TMCI · IEX Real-Time Price · USD
8.91
-0.04 (-0.45%)
Dec 6, 2023, 4:00 PM EST - Market closed
-0.45%
Market Cap 574.82M
Revenue (ttm) 174.68M
Net Income (ttm) -47.66M
Shares Out 61.68M
EPS (ttm) -0.78
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 995,796
Open 9.12
Previous Close 8.95
Day's Range 8.83 - 9.14
52-Week Range 5.27 - 27.97
Beta 0.17
Analysts Strong Buy
Price Target 18.92 (+112.35%)
Earnings Date Nov 9, 2023

About TMCI

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision; and Adductoplasty system desi... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Apr 23, 2021
Employees 423
Stock Exchange NASDAQ
Ticker Symbol TMCI
Full Company Profile

Financial Performance

In 2022, TMCI's revenue was $141.84 million, an increase of 50.22% compared to the previous year's $94.42 million. Losses were -$42.82 million, 106.4% more than in 2021.

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for TMCI stock is "Strong Buy." The 12-month stock price forecast is $18.92, which is an increase of 112.35% from the latest price.

Price Target
$18.92
(112.35% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Treace Medical Concepts Reports Third Quarter 2023 Financial Results

PONTE VEDRA, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgica...

27 days ago - GlobeNewsWire

Treace to Present at Stifel 2023 Healthcare Conference

PONTE VEDRA, Fla., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgica...

5 weeks ago - GlobeNewsWire

Treace to Report Third Quarter 2023 Financial Results

Company to Host Conference Call on Thursday, November 9, 2023 at 4:30 pm ET Company to Host Conference Call on Thursday, November 9, 2023 at 4:30 pm ET

7 weeks ago - GlobeNewsWire

Treace Highlights New Product Innovations and Updated ALIGN3D™ Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2023

PONTE VEDRA, Fla., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgic...

2 months ago - GlobeNewsWire

Treace Medical Concepts Announces New Patent Covering Instrumented Bunion Correction Procedures and Milestone 50th U.S. Patent

PONTE VEDRA, Fla., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgic...

2 months ago - GlobeNewsWire

Treace Medical Concepts Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures

Further Expands Market Opportunity to Include Hammertoe Correction Company Receives 510(k) Clearance for Second-Generation SpeedPlate™ Implant Fixation Platform Ahead of Full Market Launch in Fourth Q...

3 months ago - GlobeNewsWire

Treace Announces Participation in the 21st Annual Morgan Stanley Global Healthcare Conference

PONTE VEDRA, Fla., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgica...

3 months ago - GlobeNewsWire

Treace Medical Concepts Appoints Nathan Minnich as Senior Vice President, Marketing

PONTE VEDRA, Fla., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgica...

3 months ago - GlobeNewsWire

Treace Medical Concepts Reports Second Quarter 2023 Financial Results

PONTE VEDRA, Fla., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgica...

4 months ago - GlobeNewsWire

Treace Announces Participation in the UBS Medtech, Tools and Genomics Summit 2023

PONTE VEDRA, Fla., July 24, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgica...

4 months ago - GlobeNewsWire

Treace to Report Second Quarter 2023 Financial Results on August 8, 2023

PONTE VEDRA, Fla., July 18, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of ha...

5 months ago - GlobeNewsWire

Treace Appoints Julie Dewey as Chief Communications and Investor Relations Officer

PONTE VEDRA, Fla., July 12, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgica...

5 months ago - GlobeNewsWire

Treace Medical Completes Acquisition of Technology Enabling Patient Specific Instrumentation and Reports on Clinical Cases Using PSI with the Lapiplasty® System

PONTE VEDRA, Fla., June 13, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgica...

6 months ago - GlobeNewsWire

Treace Medical Concepts to Acquire Technology Enabling Patient Specific Instrumentation for Foot and Ankle Surgeries

PONTE VEDRA, Fla., June 01, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgica...

6 months ago - GlobeNewsWire

TREACE INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options

NEW YORK , May 13, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace" or the "Company"...

7 months ago - PRNewsWire

Treace Medical Concepts Reports First Quarter 2023 Financial Results

PONTE VEDRA, Fla., May 08, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical...

7 months ago - GlobeNewsWire

TREACE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options

NEW YORK , April 29, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace" or the "Compan...

7 months ago - PRNewsWire

Treace Announces Participation in the Bank of America 2023 Healthcare Conference

PONTE VEDRA, Fla., April 26, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgic...

8 months ago - GlobeNewsWire

Treace to Report First Quarter 2023 Financial Results on May 8, 2023

PONTE VEDRA, Fla., April 20, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of h...

8 months ago - GlobeNewsWire

Treace Medical Expands Market Leading Global IP Portfolio For Bunion And Related Deformities

PONTE VEDRA, Fla., April 19, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgic...

8 months ago - GlobeNewsWire

Treace Publishes Inaugural ESG Report

PONTE VEDRA, Fla., April 04, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgic...

8 months ago - GlobeNewsWire

Treace Medical Concepts Reports Fourth Quarter and Full Year 2022 Financial Results

PONTE VEDRA, Fla., March 07, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgic...

9 months ago - GlobeNewsWire

Treace Medical Announces Settlement of Lawsuit Again Fusion Orthopedics

PONTE VEDRA, Fla., March 03, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in th...

9 months ago - GlobeNewsWire

Treace Medical Announces Settlement of Lawsuit Against Fusion Orthopedics

PONTE VEDRA, Fla., March 03, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in th...

9 months ago - GlobeNewsWire

Dispute Between Treace Medical and Fusion Orthopedics Resolved

MESA, Ariz.--(BUSINESS WIRE)--Treace Medical Concepts, Inc. (NASDAQ: TMCI) (“Treace Medical”) and Fusion Orthopedics, LLC (“Fusion Orthopedics”) jointly announce that they have reached an amicable res...

9 months ago - Business Wire